IFP Advisors’s Cytokinetics CYTK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $33.4K | Hold |
506
| – | – | ﹤0.01% | 2482 |
|
|
2025
Q4 | $32.2K | Buy |
506
+48
| +10% | +$2.99K | ﹤0.01% | 2449 |
|
|
2025
Q3 | $25.2K | Buy |
458
+147
| +47% | +$6.06K | ﹤0.01% | 2466 |
|
|
2025
Q2 | $20.5K | Buy |
311
+68
| +28% | +$2.37K | ﹤0.01% | 2532 |
|
|
2025
Q1 | $9.77K | Sell |
243
-2
| -0.8% | -$92 | ﹤0.01% | 2588 |
|
|
2024
Q4 | $11.5K | Sell |
245
-25
| -9% | -$1.3K | ﹤0.01% | 2473 |
|
|
2024
Q3 | $14.3K | Buy |
270
+10
| +4% | +$557 | ﹤0.01% | 2294 |
|
|
2024
Q2 | $14.1K | Buy |
260
+243
| +1,429% | +$14.7K | ﹤0.01% | 2218 |
|
|
2024
Q1 | $1.19K | Buy |
+17
| New | +$1.31K | ﹤0.01% | 2823 |
|
|
2023
Q1 | – | Sell |
-10
| Closed | -$1K | – | 3595 |
|
|
2022
Q4 | $1K | Sell |
10
-1,002
| -99% | -$43.1K | ﹤0.01% | 4313 |
|
|
2022
Q3 | $10K | Hold |
1,012
| – | – | ﹤0.01% | 3626 |
|
|
2022
Q2 | $10K | Hold |
1,012
| – | – | ﹤0.01% | 3386 |
|
|
2022
Q1 | $10K | Buy |
1,012
+999
| +7,685% | +$35.5K | ﹤0.01% | 3386 |
|
|
2021
Q4 | $1K | Hold |
13
| – | – | ﹤0.01% | 2973 |
|
|
2021
Q3 | $1K | Sell |
13
-2
| -13% | -$59 | ﹤0.01% | 3006 |
|
|
2021
Q2 | $0 | Sell |
15
-39
| -72% | -$916 | ﹤0.01% | 3360 |
|
|
2021
Q1 | $1K | Sell |
54
-14
| -21% | -$299 | ﹤0.01% | 2808 |
|
|
2020
Q4 | $1K | Buy |
+68
| New | +$1.24K | ﹤0.01% | 2741 |
|
|
2020
Q3 | – | Hold |
0
| – | – | – | 3056 |
|
|
2016
Q1 | – | Sell |
-2,700
| Closed | -$28K | – | 2578 |
|
|
2015
Q4 | $28K | Buy |
+2,700
| New | +$26.5K | ﹤0.01% | 1962 |
|
Other funds holding CYTK
VPM
VCM
ACA
